Your browser doesn't support javascript.
loading
Paradoxical response in a patient with non-small cell lung cancer who received nivolumab followed by anti-Mycobacterium tuberculosis agents.
Takata, So; Koh, Genju; Han, Yuki; Yoshida, Hiroko; Shiroyama, Takayuki; Takada, Hiromune; Masuhiro, Kentarou; Nasu, Shingo; Morita, Satomu; Tanaka, Ayako; Hashimoto, Syouji; Uriu, Kiyoaki; Suzuki, Hidekazu; Tamura, Yoshitaka; Okamoto, Norio; Nagai, Takayuki; Hirashima, Tomonori.
Afiliação
  • Takata S; Department of Thoracic Oncology, Osaka Prefectural Hospital Organization Osaka Habikino Medical Center, 3-7-1, Habikino, Habikino City, Osaka, 583-8588, Japan. Electronic address: sotakata@imed3.med.osaka-u.ac.jp.
  • Koh G; Department of Medical Oncology, Yao Tokushukai General Hospital, 1-17, Wakakusa Town, Yao City, Osaka, 581-0011, Japan.
  • Han Y; Department of Infectious Disease, Osaka Prefectural Hospital Organization Osaka Habikino Medical Center, 3-7-1, Habikino, Habikino City, Osaka, 583-8588, Japan.
  • Yoshida H; Department of Clinical Laboratory, Osaka Prefectural Hospital Organization Osaka Habikino Medical Center, 3-7-1, Habikino, Habikino City, Osaka, 583-8588, Japan.
  • Shiroyama T; Department of Thoracic Oncology, Osaka Prefectural Hospital Organization Osaka Habikino Medical Center, 3-7-1, Habikino, Habikino City, Osaka, 583-8588, Japan.
  • Takada H; Department of Thoracic Oncology, Osaka Prefectural Hospital Organization Osaka Habikino Medical Center, 3-7-1, Habikino, Habikino City, Osaka, 583-8588, Japan.
  • Masuhiro K; Department of Thoracic Oncology, Osaka Prefectural Hospital Organization Osaka Habikino Medical Center, 3-7-1, Habikino, Habikino City, Osaka, 583-8588, Japan.
  • Nasu S; Department of Thoracic Oncology, Osaka Prefectural Hospital Organization Osaka Habikino Medical Center, 3-7-1, Habikino, Habikino City, Osaka, 583-8588, Japan.
  • Morita S; Department of Thoracic Oncology, Osaka Prefectural Hospital Organization Osaka Habikino Medical Center, 3-7-1, Habikino, Habikino City, Osaka, 583-8588, Japan.
  • Tanaka A; Department of Thoracic Oncology, Osaka Prefectural Hospital Organization Osaka Habikino Medical Center, 3-7-1, Habikino, Habikino City, Osaka, 583-8588, Japan.
  • Hashimoto S; Department of Clinical Laboratory, Osaka Prefectural Hospital Organization Osaka Habikino Medical Center, 3-7-1, Habikino, Habikino City, Osaka, 583-8588, Japan.
  • Uriu K; Department of Respiratory Medicine, Yao Tokushukai General Hospital, 1-17, Wakakusa Town, Yao City, Osaka, 581-0011, Japan.
  • Suzuki H; Department of Thoracic Oncology, Osaka Prefectural Hospital Organization Osaka Habikino Medical Center, 3-7-1, Habikino, Habikino City, Osaka, 583-8588, Japan.
  • Tamura Y; Department of Infectious Disease, Osaka Prefectural Hospital Organization Osaka Habikino Medical Center, 3-7-1, Habikino, Habikino City, Osaka, 583-8588, Japan.
  • Okamoto N; Department of Thoracic Oncology, Osaka Prefectural Hospital Organization Osaka Habikino Medical Center, 3-7-1, Habikino, Habikino City, Osaka, 583-8588, Japan.
  • Nagai T; Department of Infectious Disease, Osaka Prefectural Hospital Organization Osaka Habikino Medical Center, 3-7-1, Habikino, Habikino City, Osaka, 583-8588, Japan.
  • Hirashima T; Department of Thoracic Oncology, Osaka Prefectural Hospital Organization Osaka Habikino Medical Center, 3-7-1, Habikino, Habikino City, Osaka, 583-8588, Japan.
J Infect Chemother ; 25(1): 54-58, 2019 Jan.
Article em En | MEDLINE | ID: mdl-30055859

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Adenocarcinoma / Carcinoma Pulmonar de Células não Pequenas / Nivolumabe / Neoplasias Pulmonares / Antibacterianos Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Adenocarcinoma / Carcinoma Pulmonar de Células não Pequenas / Nivolumabe / Neoplasias Pulmonares / Antibacterianos Idioma: En Ano de publicação: 2019 Tipo de documento: Article